The manufacturer guaranteed the positive effect and effectiveness of the drug in eliminating joint pain. Teraflex Hondrocrem Forte is registered as a medicinal product.
In accordance with paragraph 8 of part 1 of Article 24 of the Law on Advertising - advertising of medicines must not guarantee the positive effect of the advertising object, its safety, effectiveness and the absence of side effects; and in accordance with part 6 of article 38 of the Law on Advertising - the advertiser is liable for violation of the requirements of the legislation of the Russian Federation on advertising, established by part 1 of article 24 of the Law on Advertising.
FAS Russia imposed an administrative fine of two hundred thousand rubles on Bayer JSC for inappropriate advertising of the drug Teraflex Hondrocrem Forte. The commercial was distributed in December 2020 on the TV-3 Russia TV channel.
In April, the FAS Russia commission admitted that in the commercial for Teraflex Hondrocrem Forte, the manufacturer guaranteed the safety of its use, effectiveness and the absence of side effects, thereby violating the requirements of the Advertising Law.